Beyond Air, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
Beyond Air, Inc. (XAIR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of -0.67% for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-22.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2023-06-22
- Beyond Air, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2023 was -0.67%.
- Beyond Air, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2022 was -0.65%.
- Beyond Air, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2021 was -1.82%.
- Beyond Air, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2020 was -1.39%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month |
|---|---|
| 2023-03-31 | -0.67% 10-K · filed 2023-06-22 |
| 2022-03-31 | -0.65% 10-K · filed 2023-06-22 |
| 2021-03-31 | -1.82% 10-K · filed 2022-06-29 |
| 2020-03-31 | -1.39% 10-K · filed 2021-06-10 |
| 2019-03-31 | -3.71% 10-K · filed 2020-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |